Next report date
Report period
Q1 2024
EPS estimate
−0.45USD
Revenue estimate
—
−23.96 MUSD
14.04 M
Om Context Therapeutics Inc.
Sektor
Bransch
VD
Martin A. Lehr
Webbplats
Huvudkvarter
Philadelphia
Employees (FY)
5
Grundat
2015
FIGI
BBG011YW6H86
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
